Literature DB >> 10825600

Successful DNA immunisation of rats against fasciolosis.

W Kofta1, J Mieszczanek, G Płucienniczak, H Wedrychowicz.   

Abstract

The liver fluke Fasciola hepatica contributes to great economic and health losses in the cattle industry in many countries, including Poland. Unfortunately, no vaccine against fasciolosis is commercially available. We have designed a DNA vaccine and tested it in rats. Groups of male or female rats received one intramuscular injection of 50 microg of a pcDNA 3.1 vector carrying cDNA encoding for a cysteine proteinase of F. hepatica. The plasmid was diluted in saline containing 0.05% bupivacaine. Control rats were injected with empty plasmid or not injected at all. All rats were challenged with 45 metacercariae of the fluke on day 28 of the experiment. Seven weeks after the challenge infection fluke burdens were evaluated in vaccinated and control rats. Male rats vaccinated with cysteine proteinase cDNA revealed 100% protection against F. hepatica infection. Females immunised in the same way exhibited the reduction of fluke burden by 74%.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825600     DOI: 10.1016/s0264-410x(00)00095-5

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Molecular identification and characterization of leucine aminopeptidase 2, an excretory-secretory product of Clonorchis sinensis.

Authors:  Chuanhuan Deng; Jiufeng Sun; Xuerong Li; Lexun Wang; Xuchu Hu; Xiaoyun Wang; Wenjun Chen; Xiaoli Lv; Chi Liang; Wenfang Li; Yan Huang; Ran Li; Zhongdao Wu; Xinbing Yu; Jin Xu
Journal:  Mol Biol Rep       Date:  2012-06-23       Impact factor: 2.316

2.  Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis.

Authors:  Olgary Figueroa-Santiago; Bonnibel Delgado; Ana M Espino
Journal:  Diagn Microbiol Infect Dis       Date:  2011-07       Impact factor: 2.803

Review 3.  Recent Developments in Recombinant Proteins for Diagnosis of Human Fascioliasis.

Authors:  Abolfazl Mirzadeh; Farid Jafarihaghighi; Elham Kazemirad; Shokouh Shahrokhi Sabzevar; Mohammad Hossein Tanipour; Mehdi Ardjmand
Journal:  Acta Parasitol       Date:  2020-09-24       Impact factor: 1.440

4.  Immune response of rats vaccinated orally with various plant-expressed recombinant cysteine proteinase constructs when challenged with Fasciola hepatica metacercariae.

Authors:  Malgorzata Kesik-Brodacka; Agnieszka Lipiec; Monika Kozak Ljunggren; Luiza Jedlina; Katarzyna Miedzinska; Magdalena Mikolajczak; Andrzej Plucienniczak; Andrzej B Legocki; Halina Wedrychowicz
Journal:  PLoS Negl Trop Dis       Date:  2017-03-23

5.  Comparison of recombinant cathepsins L1, L2, and L5 as ELISA targets for serodiagnosis of bovine and ovine fascioliasis.

Authors:  Victoria Martínez-Sernández; María J Perteguer; Ana Hernández-González; Mercedes Mezo; Marta González-Warleta; Ricardo A Orbegozo-Medina; Fernanda Romarís; Esperanza Paniagua; Teresa Gárate; Florencio M Ubeira
Journal:  Parasitol Res       Date:  2018-03-21       Impact factor: 2.289

6.  A Preliminary Study of a Lettuce-Based Edible Vaccine Expressing the Cysteine Proteinase of Fasciola hepatica for Fasciolosis Control in Livestock.

Authors:  Agnieszka Wesołowska; Monika Kozak Ljunggren; Luiza Jedlina; Katarzyna Basałaj; Andrzej Legocki; Halina Wedrychowicz; Małgorzata Kesik-Brodacka
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

7.  A large-scale epidemiological investigation on trematode infections in small ruminants in Bangladesh.

Authors:  Anita Rani Dey; Nurjahan Begum; Md Taohidul Islam; Mohammad Zahangir Alam
Journal:  Vet Med Sci       Date:  2022-02-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.